Current status: Answered by Maree Todd on 10 August 2026
To ask the Scottish Government what plans it has to carry out a rapid review of the available evidence on the risks associated with the long-term use of the contraceptive injection, Depo-Provera.
The Medicines and Healthcare products Regulatory Agency (MHRA) has responsibility for the quality, safety, and efficacy of medicines through its licensing and pharmacovigilance functions, which are reserved matters.
The MHRA continues to closely monitor the safety of Depo-Provera®, as it does with all licensed medicines, and is examining recent data and seeking advice from experts on the need for any further action. Given this ongoing work, I have no plans to commission a separate evidence review.